Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07393659
PHASE3

A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment

Sponsor: ViiV Healthcare

View on ClinicalTrials.gov

Summary

The purpose of this study is to provide continued access to the study treatment for participants from previous ViiV Healthcare studies who are still benefiting from it and do not have local access after completing the parent study. This continued access will also allow further collection of safety data. Eligible participants are those who completed a ViiV Healthcare-sponsored or collaborative parent study and are currently experiencing clinical benefit. The Sponsor will periodically review the study to consider other treatment access options.

Official title: A Phase 3b, Open-label, Multicenter, Continued Access Study for Participants Transitioning From ViiV Healthcare Sponsored or ViiV Healthcare Collaborative Parent Studies for HIV Treatment

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

183

Start Date

2026-05-08

Completion Date

2030-12-30

Last Updated

2026-02-06

Healthy Volunteers

No

Conditions

Interventions

DRUG

Fostemsavir

Participants receive oral tablets with the dosages depending on the weight of the participants.

DRUG

Dolutegravir (DTG)/ Lamivudine (3TC)

Participants receive oral tablets with the dosages depending on the weight of the participants.